Healthcare & Medical Devices Global On demand · 24-48h

Global Non-human Primates in Research and Safety Testing Market Strategic Research Report

Global Non-human Primates in Research and Safety Testing Mar…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Non-human Primates in Research and Safety Testing Market
$2.77B2025
8.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Macaca Fascicularis (Cynomolgus Macaque), Rhesus Monkey (Macaca Mulatta), Others

By Application: Contract Research and Development Service Organization (CRO) Company, Scientific Research Institution, Colleges and Universities, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Vanny Bio Research, HZ-Bio, Envigo (Inotiv), JOINN LABORATORIES, WuXi AppTec, Jingang Biotech, Charles River, Pharmaron, Xishan Zhongke, ONPRC (Oregon National Primate Research Center), CNPRC (California National Primate Research Center), Sichuan Hengshu Bio-Technolog, Topgene Biotechnology, Primate Products, Inc. (PPI), Sichuan Green-House Biotech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 112 pages
Market size 2025
$2.77B
Billion USD
Forecast CAGR
8.1%
2025-2032
Forecast 2032
$4.8B
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Non-human Primates in Research and Safety Testing market size is predicted to grow from US$ 2,768 million in 2025 to US$ 4,725 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.

This report studies Laboratory Nonhuman Primates (NHPs) or Laboratory Non-human Primate. Nonhuman primates (NHPs) are a group of mammals composed of simians – monkeys and apes – and prosimians, such as lemurs., they are the closest animal models to humans regarding genetics, physiology and behavior. Experiments on non-human primates (NHPs) have brought about important advances in biology and medicine. Primates often play a crucial role in the safety testing of new drugs and in research aimed at understanding how the brain works and how to prevent infectious diseases in humans. Currently, the typical models of Laboratory Nonhuman Primates (NHPs) include Envigo (Inotiv)"s Cynomolgus macaques, HZ-Bio"s Macaca Fascicularis and Rhesus Monkey, etc.

The Laboratory Nonhuman Primates (NHPs) market mainly driven by downstream market andrelaveent pharmaceutical and clinical policy. The continuous advancements in biomedical research, including studies related to diseases, genetics, neuroscience, and drug development, often require the use of animal models. Laboratory monkeys, due to their genetic and physiological similarities to humans, are valuable in such research.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-human Primates in Research and Safety Testing market?

What factors are driving Non-human Primates in Research and Safety Testing market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-human Primates in Research and Safety Testing market opportunities vary by end market size?

How does Non-human Primates in Research and Safety Testing break out by Type, by Application?

This report presents a comprehensive overview of the global Non-human Primates in Research and Safety Testing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Macaca Fascicularis (Cynomolgus Macaque)
  • Rhesus Monkey (Macaca Mulatta)
  • Others

Segment by Application

  • Contract Research and Development Service Organization (CRO) Company
  • Scientific Research Institution
  • Colleges and Universities
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Non-human Primates in Research and Safety Testing market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Contract Research and Development Service Organization (CRO) Company, Scientific Research Institution, Colleges and Universities evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Non-human Primates in Research and Safety Testing Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.77B
2025
Forecast
$4.8B
2032
CAGR
8.1%
2025–2032
Области
5
global
Key companies
Vanny Bio ResearchHZ-BioEnvigo (Inotiv)JOINN LABORATORIESWuXi AppTecJingang BiotechCharles RiverPharmaron
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Macaca Fascicularis (Cynomolgus Macaque)Rhesus Monkey (Macaca Mulatta)Others
By Application
Contract Research and Development Service Organization (CRO) CompanyScientific Research InstitutionColleges and UniversitiesOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Macaca Fascicularis (Cynomolgus Macaque)
  • 3.1.3 Rhesus Monkey (Macaca Mulatta)
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Contract Research and Development Service Organization (CRO) Company
  • 4.1.3 Scientific Research Institution
  • 4.1.4 Colleges and Universities
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Vanny Bio Research
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 HZ-Bio
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Envigo (Inotiv)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 JOINN LABORATORIES
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 WuXi AppTec
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Jingang Biotech
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Charles River
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Pharmaron
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Xishan Zhongke
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ONPRC (Oregon National Primate Research Center)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 CNPRC (California National Primate Research Center)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Sichuan Hengshu Bio-Technolog
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Topgene Biotechnology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Primate Products, Inc. (PPI)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Sichuan Green-House Biotech
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Non-human Primates in Research and Safety Testing market size?
The global Non-human Primates in Research and Safety Testing market is estimated at US$ 2.77 billion in 2025 (base year) and is projected to reach US$ 4.72 billion by 2032.
What growth rate is expected for the Non-human Primates in Research and Safety Testing market through 2032?
The market is expected to grow at a CAGR of 8.1% from 2026 to 2032, expanding from US$ 2.77 billion in 2025 to US$ 4.72 billion in 2032, roughly 1.7 times its base-year value.
How is Non-human Primates in Research and Safety Testing defined?
This report studies Laboratory Nonhuman Primates (NHPs) or Laboratory Non-human Primate. Nonhuman primates (NHPs) are a group of mammals composed of simians – monkeys and apes – and prosimians, such as lemurs., they are the closest animal models to humans regarding genetics, physiology and behavior. Experiments on non-human primates (NHPs) have brought about important advances in biology and medicine.
How is the Non-human Primates in Research and Safety Testing market segmented by type?
By type, the market is segmented into Macaca Fascicularis (Cynomolgus Macaque), Rhesus Monkey (Macaca Mulatta) and Others.
What are the key applications of Non-human Primates in Research and Safety Testing?
Key applications covered include Contract Research and Development Service Organization (CRO) Company, Scientific Research Institution, Colleges and Universities and Other.
Which companies are profiled in the Non-human Primates in Research and Safety Testing market report?
Key players profiled include Vanny Bio Research, HZ-Bio, Envigo (Inotiv), JOINN LABORATORIES, WuXi AppTec, Jingang Biotech, Charles River and Pharmaron, among 15 companies covered in total.
What geographies does the Non-human Primates in Research and Safety Testing market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Non-human Primates in Research and Safety Testing?
The Laboratory Nonhuman Primates (NHPs) market mainly driven by downstream market andrelaveent pharmaceutical and clinical policy.
Who should buy the Non-human Primates in Research and Safety Testing market report?
The report is intended for manufacturers and solution providers, distributors and end users in Contract Research and Development Service Organization (CRO) Company, Scientific Research Institution and Colleges and Universities, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Non-human Primates in Research and Safety Testing market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.